RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.
about
Noncanocial cell death program independent of caspase activation cascade and necroptotic modules is elicited by loss of TGFβ-activated kinase 1.Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.MLKL Mediated Necroptosis Accelerates JEV-Induced Neuroinflammation in Mice.Neuroinflammation as modifier of genetically caused neurological disorders of the central nervous system: Understanding pathogenesis and chances for treatment.The in vivo evidence for regulated necrosis.RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation.Mechanisms of RIPK3-induced inflammation.Roles of Caspases in Necrotic Cell Death.Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.The Contribution of Necroptosis in Neurodegenerative Diseases.Necroptosis and Cancer.Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis.RIPK3 in cell death and inflammation: the good, the bad, and the ugly.Ferroptosis: bug or feature?Necroptosis in neurodegenerative diseases: a potential therapeutic target.Thioredoxin-1 actively maintains the pseudokinase MLKL in a reduced state to suppress disulfide bond-dependent MLKL polymer formation and necroptosis.Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative DisordersRole of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications.Oxidized low-density lipoprotein induced mouse hippocampal HT-22 cell damage via promoting the shift from autophagy to apoptosis.CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens.ABIN-1 regulates RIPK1 activation by linking Met1 ubiquitylation with Lys63 deubiquitylation in TNF-RSC.Necroptosis activation in Alzheimer's disease.Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?Multiple Proteinopathies in Familial ALS Cases With Optineurin Mutations.miRNA-21 ablation protects against liver injury and necroptosis in cholestasis.Generation of a Motor Nerve Organoid with Human Stem Cell-Derived Neurons.RIPK1 mediates a disease-associated microglial response in Alzheimer's disease.Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.PELI1 functions as a dual modulator of necroptosis and apoptosis by regulating ubiquitination of RIPK1 and mRNA levels of c-FLIP.Structural insights into the ubiquitin recognition by OPTN (optineurin) and its regulation by TBK1-mediated phosphorylation.Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis.CNS inflammation and neurodegeneration.Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson's Disease Models.The Structure of the Necrosome RIPK1-RIPK3 Core, a Human Hetero-Amyloid Signaling Complex.Lysosomal damage after spinal cord injury causes accumulation of RIPK1 and RIPK3 proteins and potentiation of necroptosis.Optineurin Functions for Optimal Immunity.Oxytosis/Ferroptosis-(Re-) Emerging Roles for Oxidative Stress-Dependent Non-apoptotic Cell Death in Diseases of the Central Nervous System.Necroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression.MLKL Requires the Inositol Phosphate Code to Execute Necroptosis.Necroptosis in development and diseases.
P2860
Q30352395-BB222D42-1451-4BE0-87DE-AC16FDAEBC4AQ30848999-0367303F-A237-4FBD-8DF1-8EF28A8045E3Q37670431-6E414175-F8AD-4383-994B-BF82D25C7F5AQ38751654-53CC28EC-DBBB-4012-8A3A-9684BA97D440Q38809791-96C1F2A2-9CE1-437C-B7AC-D62BBA5835E0Q38862204-EF8097FB-F10C-4D15-9989-32773F842CF6Q39038663-A0EC6075-9290-47DB-91FB-BC427677B583Q39041502-0EA42951-15AE-4D8D-BFBD-C178F19A95FBQ39105381-6759ABE1-CD26-441A-9DF9-DF49F08A4A9CQ39223683-3154A7D6-5F6D-41C2-AC78-3F1A05192601Q39268644-36882775-2311-4412-8A5B-5DC7FDD4B530Q39271545-E8BFFD7C-13EF-4418-827E-8A89D767E67FQ39277433-CFDA7D69-67BD-4EAC-9E35-FD047E9934CCQ39277487-27BDE661-3B0E-444C-B503-B486B0786EE3Q39404657-C0E598E7-D3FE-402D-B120-AE1E51C3112DQ40063923-1718A19D-1559-4AA3-8CE9-66DCFE7F8451Q41475139-011856BD-4CFF-4909-8299-778259E0FEEFQ41488070-0838006F-31EB-4189-96BE-521AFC11E195Q41913283-2D1C9412-1601-4182-B894-1ECE170044D9Q42376104-9BCCB773-C41D-46A0-BC58-0741B53933DDQ46795485-4AB86AFE-C881-41E8-B99B-BA2940539304Q46962553-A5C3FC8D-56AE-4061-9A3E-81A380E359A3Q47108927-117F98C8-6AF3-451C-9F1C-EBEEBC6B9697Q47260493-30ED0918-9795-41A1-819F-4F99EB588FCEQ47304510-1AA1E021-0FA5-4739-83DB-6DC2941196CBQ47377037-0B49A73F-E1A0-4B15-A1F1-3091675559A2Q47806841-89EA52E1-983C-4F08-B605-D68B2BF29376Q47843948-0015A96A-FF99-40DA-8E70-10BE70106B2DQ48112407-2A512A50-99BA-4CC9-8CB6-B308455B4AE5Q48114325-AB8924FF-1602-4731-AAE3-A14F9D7056F4Q50026384-8D6419CC-8272-4362-A995-ED8466E845A3Q50223200-ECD5C91D-E077-4891-BAF3-4B94CBDD58B4Q51738958-0B239739-799D-460E-B208-B647F86E3CA5Q52313311-4FF01F01-B42B-43D4-AE62-3EC3EADF20AFQ52691720-00BAA09A-8B6D-4208-8DB5-DDD8B6185226Q54114445-D3A773A3-1114-46E4-8140-90A587E7D846Q54946045-6A876F37-8EDC-47A0-82F7-C380670421F4Q54966844-3B774F18-687C-4EA4-9401-92D76D1D38E7Q54976684-AB6817F5-27D8-468F-A637-A727C02994D2Q54981573-E785D575-3A83-429F-B25C-A10CF235C54E
P2860
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.
@ast
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.
@en
type
label
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.
@ast
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.
@en
prefLabel
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.
@ast
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.
@en
P2093
P2860
P50
P356
P1433
P1476
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.
@en
P2093
Adnan Kasim Mookhtiar
Amanda Tomie Ouchida
Dimitry Ofengeim
Jian-bing Fan
Jiefei Geng
John Ravits
Judy Park DeWitt
Junichi Hitomi
Junying Yuan
Marcus Florez
P2860
P304
P356
10.1126/SCIENCE.AAF6803
P407
P577
2016-08-01T00:00:00Z